Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zhanfeng Bai"'
Autor:
Qian Du, Xin Xi, Jie Dong, Tongyan Zhang, Dongxuan Li, Yuzhu Dong, Wenjun Li, Guili Huang, Jun Zhu, Hailong Ran, Jinghui Gou, Cheng Chen, Zhanfeng Bai, Qinglong Liu, Wei Yao, Lei Zhang, Yutian Bi, Songqing Liu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and aim: Infectious disease (ID) consultation can improve multidrug-resistant organism (MDRO) treatment outcomes. However, the impact of clinical pharmacists’ ID consultation on MDRO therapy, especially early initiation, has not been rep
Externí odkaz:
https://doaj.org/article/3ddd4184a31e484ab9ac1716c56002ff
Autor:
Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing Liu
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1109 (2023)
Antibacterial drug exposure (ADE) is a well-known potential risk factor for Clostridium difficile infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI
Externí odkaz:
https://doaj.org/article/d8a56f715cf04fb2b989d43273afe8bc
Autor:
Liu, Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing
Publikováno v:
Antibiotics; Volume 12; Issue 7; Pages: 1109
Antibacterial drug exposure (ADE) is a well-known potential risk factor for Clostridium difficile infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e071db26eb200f034cce3cfecf40d523